You might want to take a look at Gossamer Bio Inc (GOSS) now

With 1.09 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.61 million shares. The 52-week range on GOSS shows that it touched its highest point at $1.56 and its lowest point at $0.50 during that stretch. It currently has a 1-year price target of $8.67. Beta for the stock currently stands at 1.86.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GOSS was up-trending over the past week, with a rise of 7.96%, but this was up by 15.09% over a month. Three-month performance surged to 70.56% while six-month performance rose 34.07%. The stock lost -12.23% in the past year, while it has gained 34.87% so far this year. A look at the trailing 12-month EPS for GOSS yields -0.33 with Next year EPS estimates of -0.71. For the next quarter, that number is -0.17. This implies an EPS growth rate of 76.06% for this year and -151.33% for next year. EPS is expected to grow by 26.42% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 11.99%.

Float and Shares Shorts:

At present, 226.60 million GOSS shares are outstanding with a float of 182.10 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GOSS since 10 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.18161 being high and -$0.32286 being low. For GOSS, this leads to a yearly average estimate of -$0.2825. Based on analyst estimates, the high estimate for the next quarter is -$0.15 and the low estimate is -$0.22. The average estimate for the next quarter is thus -$0.19.